Preferability of Molnupiravir, an Anti-COVID-19 Drug, toward Purine Nucleosides: A Quantum Mechanical Study

Authors

Mahmoud A. A. Ibrahim, Computational Chemistry Laboratory, Chemistry Department, Faculty of Science, Minia University, Minia 61519, Egypt,School of Health Sciences, University of KwaZulu-Natal, Westville Campus, Durban 4000, South Africa
Mohammed N. I. Shehata, Computational Chemistry Laboratory, Chemistry Department, Faculty of Science, Minia University, Minia 61519, Egypt
Nayra A. M. Moussa, Computational Chemistry Laboratory, Chemistry Department, Faculty of Science, Minia University, Minia 61519, Egypt
Randa R. A. Hemia, Computational Chemistry Laboratory, Chemistry Department, Faculty of Science, Minia University, Minia 61519, Egypt

Document Type

Research Article

Publication Title

ACS Omega

Publication Date

7-18-2023

doi

10.1021/acsomega.3c03215

First Page

27553

Last Page

27565

Recommended Citation

APA Citation

Ibrahim, M. Shehata, M. Moussa, N. & Hemia, R. (2023). Preferability of Molnupiravir, an Anti-COVID-19 Drug, toward Purine Nucleosides: A Quantum Mechanical Study. ACS Omega, 8, 27553–27565. 10.1021/acsomega.3c03215
https://fount.aucegypt.edu/faculty_journal_articles/5323

MLA Citation

Ibrahim, Mahmoud A. A., et al. "Preferability of Molnupiravir, an Anti-COVID-19 Drug, toward Purine Nucleosides: A Quantum Mechanical Study." ACS Omega, vol. 8, 2023, pp. 27553–27565.
https://fount.aucegypt.edu/faculty_journal_articles/5323